COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
In this national cohort study of 28 million individuals, the results found no increased risk of 4-year all-cause mortality in individuals aged 18 to 59 years vaccinated against COVID-19, further supporting the safety of the mRNA vaccines that are widely used worldwide.
Authors
- Marie-Joëlle Jabagi (ORCID: https://orcid.org/0000-0002-7946-7759)
- Jérôme Drouin (ORCID: https://orcid.org/0000-0003-2017-7041)
- Stéphane Le Vu (ORCID: https://orcid.org/0000-0002-1303-8281)
- Marion Bertrand (ORCID: https://orcid.org/0000-0002-4115-7093)
- Rosemary Dray‐Spira (ORCID: https://orcid.org/0000-0001-7646-3667)
- Valérie Olié (ORCID: https://orcid.org/0000-0002-4837-1930)
- Laura Semenzato (ORCID: https://orcid.org/0000-0002-8305-3487)
- M. Zureik
- Jérémie Botton (ORCID: https://orcid.org/0000-0002-4814-6370)
- Alain Weill (ORCID: https://orcid.org/0000-0001-8687-9092)
- François Cuenot (ORCID: https://orcid.org/0000-0003-4586-4366)
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (FR)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.46822
- Citations
- 6
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 8.38